Anthrax: clinical features, pathogenesis, and potential biological warfare threat.
Friedlander
A M
AM
Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.
D000881:Anthrax / Q000175:diagnosis / Q000382:microbiology / Q000628:therapy* / Q000635:transmission; D022122:Anthrax Vaccines; D000890:Anti-Infective Agents / Q000008:administration & dosage / Q000627:therapeutic use; D001408:Bacillus anthracis / Q000302:isolation & purification / Q000472:pathogenicity; D001694:Biological Warfare; D024841:Fluoroquinolones; D005544:Forecasting; D006801:Humans; D016920:Meningitis, Bacterial / Q000175:diagnosis / Q000628:therapy; D010406:Penicillins / Q000008:administration & dosage / Q000627:therapeutic use*
D022122:Anthrax Vaccines; D000890:Anti-Infective Agents; D024841:Fluoroquinolones; D010406:Penicillins